Results 221 to 230 of about 25,697 (255)
Some of the next articles are maybe not open access.

Entrepreneurial patent management in pharmaceutical startups

Drug Discovery Today, 2016
Startups fill an increasingly important role as innovators in the pharmaceutical industry, and patenting is typically central to their success. This article aims to explore patent management in pharmaceutical startups. The results show that startups need to deal with several challenges related to patenting and an 'entrepreneurial' approach to patent ...
Marcus, Holgersson   +2 more
openaire   +2 more sources

Balancing access to pharmaceuticals with patent rights

Monash Bioethics Review, 2003
It is generally recognised that public health problems in the developing world are dire and that the rest of the world has a moral commitment to provide assistance. Yet many of the world's poor are unable to access essential pharmaceuticals simply because products that are under patent are too expensive and cheaper generics are not available.
openaire   +2 more sources

Pharmaceutical Research and Development and the Patent System

International Journal of Health Services, 2005
The pharmaceutical industry routinely exaggerates its expenditures on research and development, but it does spend billions annually. But not all R&D is equally important. The patent-based system provides incentives to invest heavily in marketing and marketing-related measures masquerading as research.
openaire   +2 more sources

Patents for Critical Pharmaceuticals: The AZT Case

American Journal of Law & Medicine, 1991
Patents and other statutory types of market protections are used in the United States to promote scientific research and innovation. This incentive is especially important in research intensive fields such as the pharmaceutical industry. Unfortunately, these same protections often result in higher monopoly pricing once a successful product is brought ...
openaire   +2 more sources

The Extraterritoriality of US Patents on the Pharmaceutical Industry

Pharmaceutical Patent Analyst, 2014
As pharmaceutical industries have rapidly modernized and globalized, borders have been blurred and multiple entities in different countries are now involved with the manufacture, supply, distribution, dispensing and administration of even a single drug in the pharmaceutical industry. The cross jurisdictional nature of the modern pharmaceutical industry
openaire   +2 more sources

Patent Searching in a Pharmaceutical Company

Journal of Chemical Information and Computer Sciences, 1978
Trisha M. Johns, Dorothy I. Ryno
openaire   +1 more source

Pharmaceutical patent challenges — time for reassessment?

Nature Reviews Drug Discovery, 2004
For nearly 15 years after the passage of the Hatch-Waxman Act in 1984, generics drug companies took little advantage of its provisions, which provided financial incentives to them for challenging the patents of branded pharmaceutical products. However, during the past 3-5 years, generics manufacturers have dramatically increased the number of patent ...
openaire   +2 more sources

Pharmaceutical; trademark; patents; news

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 2010
Richard Milchior   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy